Atlas Trials

Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes

Clinical trial NCT02715258 · COMPLETED

Trial details

NCT number
NCT02715258
Sponsor
Theracos
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2016-03-01
Primary completion
2017-04-01
Enrollment
210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.